SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNS Inc. (CNXS) Makers of the Breath Right
CNXS 0.000010000.0%Feb 6 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MrBluff who wrote (327)12/31/1997 5:53:00 PM
From: Donald carlson  Read Replies (1) of 432
 
My comments are in regard to return on investment. So far this year the company has achieved very little growth in anything except S&M costs. Domestic revenue and sell through looks like it will be up <10% for the year and qtr. as the analysts project Earnings growth is negative. Trials when I asked the CFO last week are at 12% total. That's at best 2% total increase for the year. Not much growth for new product, and very little return on the invested S&M dollars. How much should CNS spend? That depends on the return. Unless growth is going to be to substantially up from the current level perhaps they should be cutting back on the S&M and start producing some shareholder return.
Regards
DGC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext